Peroxisome Proliferator-Activated Receptors (PPARs) , atherothrombosis process and the interventionist cardiologist
Barrera-Ramírez, C.F.; Pineda-Pompa, L.R.ón.; Guzmán, C.E.
Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 56(5): 686-687
2004
ISSN/ISBN: 0034-8376 PMID: 15776873 Document Number: 574652
Document emailed within 1 workday
Related Documents
Guan, Y. 2002: Targeting peroxisome proliferator-activated receptors (PPARs) in kidney and urologic disease Minerva Urologica e Nefrologica 54(2): 65-79Alemán, G.; Torres, N.; Tovar, A.R. 2004: Peroxisome proliferator-activated receptors (PPARs) in obesity and insulin resistance development Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 56(3): 351-367
Bełtowski, J.; Wójcicka, G.; Jamroz, A. 2003: Peroxisome proliferator-activated receptors (PPAR) in pathophysiology of the circulatory system and prospective use of agonists of these receptors in therapy Postepy Higieny i Medycyny Doswiadczalnej 57(2): 199-217
Norata, G.D.; Pellegatta, F.; Catapano, A.L. 2003: Peroxisome proliferator activated receptors and cardiovascular disorders Italian Heart Journal. Suppl: Official Journal of the Italian Federation of Cardiology 4(1): 8-18
Knapp, P.ł; Jarzabek, K.; Błachnio, A.; Zbroch, T. 2006: The role of peroxisome proliferator-activated receptors (PPAR) in carcinogenesis Ginekologia Polska 77(8): 643-651
Verma, S.; Szmitko, P.E. 2006: The vascular biology of peroxisome proliferator-activated receptors: modulation of atherosclerosis Canadian Journal of Cardiology 22(Suppl): 12b-17b
Lin, Y.; Gu, S-jun.; Wu, M.; Chen, Q.; Zhou, Z-yuan.; Yu, H.; Zhang, L-jun.; Luo, W-shu.; Guo, Z-rong. 2012: Association between peroxisome proliferator-activated receptors gene polymorphism and essential hypertension Zhonghua Liu Xing Bing Xue Za Zhi 33(6): 597-601
Maver, A.; Medica, I.; Salobir, B.; Tercelj-Zorman, M.; Sabovic, M.; Petrovic, D.; Peterlin, B. 2008: Peroxisome proliferator-activated receptor gamma/Pro12Ala polymorphism and peroxisome proliferator-activated receptor gamma coactivator-1 alpha/Gly482Ser polymorphism in patients with sarcoidosis Sarcoidosis Vasculitis and Diffuse Lung Diseases: Official Journal of Wasog 25(1): 29-35
Jiao, M.; Ren, F.; Zhou, L.; Duan, Z.; Zhao, C. 2014: The protective role of peroxisome proliferator activated receptors-α and pathomechanism in D-galactosamine/lipopolysaccharide- induced acute liver failure in rats Zhonghua Nei Ke Za Zhi 53(9): 730-734
Sakai, M.; Matsushima-Hibiya, Y.; Nishizawa, M.; Nishi, S. 1995: Suppression of rat glutathione transferase P expression by peroxisome proliferators: interaction between Jun and peroxisome proliferator-activated receptor alpha Cancer Research 55(22): 5370-5376
Ye, P.; Hu, X.; Zhao, Y. 2002: The increase in plasminogen activator inhibitor type-1 expression by stimulation of activators for peroxisome proliferator-activated receptors in human endothelial cells Chinese Medical Sciences Journal 17(2): 112-116
Strakova, N.; Ehrmann, J.; Bartos, J.; Malikova, J.; Dolezel, J.; Kolar, Z. 2005: Peroxisome proliferator-activated receptors (PPAR) agonists affect cell viability, apoptosis and expression of cell cycle related proteins in cell lines of glial brain tumors Neoplasma 52(2): 126-136
Zhong, C-bin.; Zhu, X-jun.; Liu, Z-rong.; Gao, X-ping.; Wang, X-chao. 2005: Design, synthesis and insulin-sensitizing activity of some peroxisome proliferator-activated gamma agonists Yao Xue Xue Bao 40(2): 136-140
Kitamura, Y.; Shimohama, S.; Koike, H.; Kakimura, J.i.; Matsuoka, Y.; Nomura, Y.; Gebicke-Haerter, P.J.; Taniguchi, T. 1999: Increased expression of cyclooxygenases and peroxisome proliferator-activated receptor-gamma in Alzheimer's disease brains Biochemical and Biophysical Research Communications 254(3): 582-586
Peters, J.M.; Zhou, Y.C.; Ram, P.A.; Lee, S.S.; Gonzalez, F.J.; Waxman, D.J. 1996: Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta-sulfate Molecular Pharmacology 50(1): 67-74
Józkowicz, A.; Huk, I.; Nigisch, A.; Cisowski, J.ła.; Weigel, G.; Dulak, J.óz. 2003: Prostaglandin-J(2) upregulates expression of matrix metalloproteinase-1 independently of activation of peroxisome proliferator-activated receptor-gamma Acta Biochimica Polonica 50(3): 677-689
Jo, S-Hee.; Yang, C.; Miao, Q.; Marzec, M.; Wasik, M.A.; Lu, P.; Wang, Y.Lynn. 2006: Peroxisome proliferator-activated receptor gamma promotes lymphocyte survival through its actions on cellular metabolic activities Journal of Immunology 177(6): 3737-3745
Ylihärsilä, H.; Eriksson, J.G.; Forsén, T.; Laakso, M.; Uusitupa, M.; Osmond, C.; Barker, D.J.P. 2004: Interactions between peroxisome proliferator-activated receptor-gamma 2 gene polymorphisms and size at birth on blood pressure and the use of antihypertensive medication Journal of Hypertension 22(7): 1283-1287
Ye, P.; Hu, X.; Liu, Y.; Zhao, Y. 2003: Activation of peroxisome proliferator-activated receptor alpha in human endothelial cells increases plasminogen activator inhibitor type-1 expression Chinese Medical Journal 116(1): 29-33
Han, J.; Sun, L.; Liang, H.; Cheng, Y. 2014: Effects of 12/15-lipoxygenase antisense oligonucleotide on peroxisome proliferator-activated receptor γ translocation in primarily cultured cortical neurons after oxygen-glucose deprivation Zhonghua Yi Xue Za Zhi 94(15): 1179-1183